Total Reports
155
FDA CVM filings
Dog /
FDA CVM · 2025 release 155 reports on file
Spaniel - Springer Welsh - FDA Adverse Event Profile
Adverse-event records for Spaniel - Springer Welsh (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Spaniel - Springer Welsh ranks #202 by report volume among dog breeds - 5 of 155 reports (3.2%) recorded a death outcome.
- #202
- most-reported dog breed
- 3.2%
- death-coded report share
- 28
- Vomiting - top reaction
- 6.2 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
5
of 155 reports
Death Rate
3.2%
death-coded share
Avg Age at Report
6.2 yr
21.1 kg avg weight
Death-Coded Outcome Share
Spaniel - Springer Welsh death-coded reports 3.2%
Cross-breed median
3.2% of 155 spaniel - springer welsh reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 21.1 kg (46.5 lbs)
Top Reported Reactions
Vomiting 28
Lack of efficacy - NOS 14
Lethargy (see also Central nervous system depression in 'Neurological') 13
Digestive tract disorder NOS 11
Seizure NOS 11
Other abnormal test result NOS 10
Diarrhoea 9
INEFFECTIVE, ASCARIDS NOS 8
Most Referenced Drugs
Ivermectin + Pyrantel As Pamoate Salt 28
Afoxolaner 28
Milbemycin Oxime + Spinosad 22
Fluralaner Chew Tablets 15
Oclacitinib Maleate 9
Carprofen 4
Grapiprant 4
Fluralaner 13.64% 12-Week Chew 4
Outcome Breakdown
Outcome Unknown
62 (40.0%)
Recovered/Normal
51 (32.9%)
Ongoing
34 (21.9%)
Euthanized
5 (3.2%)
Recovered with Sequela
3 (1.9%)
Gender Distribution
Female 79 (51.0%)
Male 74 (47.7%)
Unknown 2 (1.3%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 1 | |
| 2011 | 4 | |
| 2012 | 7 | |
| 2013 | 5 | |
| 2014 | 14 | |
| 2015 | 21 | |
| 2016 | 8 | |
| 2017 | 21 | |
| 2018 | 12 | |
| 2019 | 10 | |
| 2020 | 8 | |
| 2021 | 6 | |
| 2022 | 5 | |
| 2023 | 12 | |
| 2024 | 15 | |
| 2025 | 6 | |
Spaniel - Springer Welsh Pet Health Insights
Spaniel - Springer Welsh accounts for 155 FDA adverse event reports, ranking #202 by volume among dog breeds, with 5 reports (3.2%) coded as a death outcome. Mean age at report: 6.2 years, average weight 21.1 kg (46.5 lbs).
Top reported signs: Vomiting (28), Lack of efficacy - NOS (14), Lethargy (see also Central nervous system depression in 'Neurological') (13). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (28 reports), followed by Afoxolaner (28) and Milbemycin Oxime + Spinosad (22).
Outcome coding on 155 status-recorded reports is dominated by Outcome Unknown (40.0%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Australian Kelpie
156 reports · 1.9% death rate
Collie - Smooth-haired
152 reports · 11.2% death rate
Dachshund - Standard Wire-haired
152 reports · 2.6% death rate
Terrier - Manchester
159 reports · 5.0% death rate
Spitz (unspecified)
150 reports · 1.3% death rate
Setter (unspecified)
161 reports · 4.3% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Spaniel - Springer Welsh? ▼
There are 155 adverse event reports involving Spaniel - Springer Welsh in the FDA database, with 5 reports involving death (3.2% death rate). Spaniel - Springer Welsh ranks #202 by report volume.
What are the most common adverse reactions reported for Spaniel - Springer Welsh? ▼
The most commonly reported adverse reactions for Spaniel - Springer Welsh are Vomiting (28 reports), Lack of efficacy - NOS (14 reports), Lethargy (see also Central nervous system depression in 'Neurological') (13 reports), Digestive tract disorder NOS (11 reports), Seizure NOS (11 reports).
What drugs are most frequently associated with Spaniel - Springer Welsh adverse events? ▼
The drugs most frequently referenced in Spaniel - Springer Welsh adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (28 reports), Afoxolaner (28 reports), Milbemycin Oxime + Spinosad (22 reports), Fluralaner Chew Tablets (15 reports), Oclacitinib Maleate (9 reports).
What is the average age of Spaniel - Springer Welsh in adverse event reports? ▼
The average age of Spaniel - Springer Welsh at the time of adverse event reports is 6.2 years, with an average weight of 21.1 kg (46.5 lbs).
Does a high number of adverse event reports mean Spaniel - Springer Welsh is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spaniel - Springer Welsh safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.